Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikash Sinha

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Pharmaceutical Research|March 14, 2014
Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discoveryIrena Loryan, Vikash Sinha, Claire Mackie, et al.
The Neurohospitalist|January 12, 2016
A National Perspective of Do-Not-Resuscitate Order Utilization Predictors in Intracerebral HemorrhageAchint A Patel, Abhimanyu Mahajan, Alexandre Benjo, et al.
Journal of Clinical Pharmacology|March 6, 2018
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc AnalysisMaarten Timmers, Vikash Sinha, Borje Darpo, et al.
The British Journal of Dermatology|December 21, 2024
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR studyVimal H Prajapati, Marieke M B Seyger, Dagmar Wilsmann-Theis, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitorMaarten Timmers, Bianca Van Broeck, Steven Ramael, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pharmaceutical Research|March 14, 2014
Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discoveryIrena Loryan, Vikash Sinha, Claire Mackie, et al.
The Neurohospitalist|January 12, 2016
A National Perspective of Do-Not-Resuscitate Order Utilization Predictors in Intracerebral HemorrhageAchint A Patel, Abhimanyu Mahajan, Alexandre Benjo, et al.
Journal of Clinical Pharmacology|March 6, 2018
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc AnalysisMaarten Timmers, Vikash Sinha, Borje Darpo, et al.
The British Journal of Dermatology|December 21, 2024
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR studyVimal H Prajapati, Marieke M B Seyger, Dagmar Wilsmann-Theis, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitorMaarten Timmers, Bianca Van Broeck, Steven Ramael, et al.
Pageof 2